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Multivisceral and Intestinal Transplantation 
T.E. Starzt. S. Todo. A. Tzakis. and N. Murase 
I N 1958. the year experimental liver replacement was first attempted in Chicago and Boston. mtesunai trans-
plantation was born In the same crib and involved many of 
the same problems and contributors. Eighteen yean be-
fore Wall'sl and Benichou's':: contributions for prolonged 
liver preservation. Richard Lillehei gave a repon at the 
1959 Amencan Surgical Assoc:iation. describing the pres-
ervation of intestinal grafts by immersing them in iced 
saline. J Owen Wangensteen. Lillehei's chainnan at the 
University of Minnesota. dismissed the cool reception 
given this paper by citing Benjamin Franklin's report two 
centuries before to cnticisms about some matter of debat-
able ment. Franklin's rhetoncal reply was "What IS the 
goO<l oi a newborn baby'?" Well. who can say·? The 
Intestinal babv was premature and remaJ.ned ICU-bound 
for 30 years. 
. .l..t first. Its fraternal twin. liver transplantation. fared 
only slightly better. The use of the two organs togelhcr 
(plus more, in an organ complex (Fig I) was lampooned at 
Fig 1. Schema1Ic view of the tran8DIIInI8d tissues and 1tleir 
and)mIC relatiCn to the hoSt. The grdlct tIsa.a ant noclh8ded 
(StarzI TE. et Ill: Mus nomoa ........ , otabdal ..... 0I'g8ft8., 
doga. SUIfJ FonIn 28.. 1980. r~ With 1*"-"'" 
the Surgical Forum of the American College of Surgeons 
of \96(t by a discussant who asked. "Why not just carry 
the anesthetIZed dog from one table to anolher?" The 
graft in question included all of the inua-abdonunal vis-
cera. After this very difficult operation. only five of 38 of 
the unmodified recipients survived perioperatively. there-
after living for 5 VI to 9 days. The two questions which 
prompted these experiments" were discussed in a more 
cORq)lete paper.' They are stiU incompletely answered as 
we nave heard throughout this meeung. 
One nuclear issue was whelher rejection of the complex 
of organs was less than that of the individual organs alone. 
This appeared to be the case: "Despite this limitauon ID 
the interpretation of data. there is evidence that the 
relation to the host of the multiple organ graft is quantl-
tively different than that of the single organ liver graft. The 
greater degree of structural and functional preservation 
... in the multiple organ graft suggests mitigation of the 
rejection processK"~ 
The matter was dropped until the classical publication of 
Calnc et all> in 1969 which described. in pigs, the protection 
wilh liver transplantation of kidney and skin gratis from 
the same donor. The concept was confirmed and elabo-
rated in rats by the Japanese surgeon Naoshi Kamada/ 
whose first work was in collaboration with Calne in En-
gland. Why the liver is protective of other organs (tolero-
genic). sometimes at its own peril. is an even more pivotal 
issue today. The reason is not yet clear. but surely will be 
in lhe ncar future. For now. it is established at a practical 
level that it is easier to graft the intestine along with the 
liver from the same donor than it is to transplant It alone. 
The second fundamental question in our original papers 
was about graft-versus-host disease tGVHDl. Which was 
known at that time. but associated almost exclusively with 
bone manow Inot solid orplU transplantation. Histo-
palhologic evidence of GVHD was found in recipient 
tissues of the multiviscerai recipients. all of whom even-
tuaily developed multiple organ failure. it was remariced: 
"Conversely. evidence for a graft-versus-host rejecuon 
res.,onse is stronger in the recipients of multiple organs 
than in those receiving the liver alone ... After multiple 
organ grafts. there was evidence of host organ failure. 
From the qr~ InS1IIUt8. UnMnfty ot Pittstlurgn. 
Sc::hOOI of Medicine. PiltSburgn. Pet 118'fIWI'" 
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Examples included suppression of bone marrow activity 
and the invariable development of pulmonary edema. 
However. the precIse rules of graft and host tissues In the 
production of these changes cannot be ascertained from 
our data. E valuation of the extent of host-versus-graft and 
graft-versus-host reactions will depend on studies in which 
either the host or the graft is rendered immunologIcally 
incompetent by radiation or other meansK"~ 
Such expenments were published 13 years later in 
"unbalanced" FI hybrid rats in the classical studies by 
Monchlk and RusseU.1I Rejection and GVHD have domi-
nlUCd the intestinal field since then. Liver transplantation 
evemuaJly grew robustly while intestinal transplantation 
suffered from Runt disease in spite of the demonstration in 
Toronto. London (Ontanol. Pittsburgh. Keil. and Paris 
that the gut could be transplanted with long survIVal in 
large ammals although with great difficulty. About a dozen 
human IntestlOaJ transplantations were periormed in the 
United States. South Amenca. Europe. and Canada be· 
tween 1967 and 1987. All failed. Other papers at this 
'iymposlum have accounted for these hlstoncally impor· 
tant cases. 
CUNICAL MULTIVISCERAL TRANSPlANTATION 
In 1987. the liver and intestine were reunited clinically in 
the same controversIal multivisceral transplant operation 
a'l originallv descnbed in dogs. Because the case proVIded 
in humans the first example of a long-functiomng intestinal 
graft.'1 it was an openmg wedge to re·examine the intestine. 
which had come to be viewed as a forbidden organ. It also 
was the parent of numerous vanations. lo 
In our report of the 1987 case. there were 42 citations. Of 
these. the one published tn early 1988 by Grant et alii 
stood out In importance above all others. These worlcers 
showed that the entire p,tg small bowel could be trans-
planted successfuUy under cyclosponne lCyA). not as a 
rare aChievement. but repeatedly. and with growth and 
maturation of the recipients. 
Having been through this experience myself with other 
organs. I understood the commitment that had been reo 
qu&red. particularly because the intravenous route of CyA 
administration had been needed. Their experiments were 
models of sophistic:a1ion. but the investigatOrs were not 
diverted by the zeatous pursUit of details. The core objec-
tive was recipient survival. It was the old-fashioned way of 
transplantation research. and I knew that we had not heard 
the last of Grant and his asSOCiates. In modem scienutic 
papers. all passion is discouraged from artIdes like these. 
but here It could not be concealed. 
Except for the spleen. the complete multivisceral graft 
conSists ot all of the intra-abdominal organs. The graft is 
enVlsioned as a grape cluster with a double central stem 
consisting of the celiac &JUS and supenor mesenteric artery 
( Fig 2). The grapes. or individua! organs. can be removed 
or retained but both anenal stem structureS are preserved 
and revascularized. A Carrel patch with the origins of 
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FIg 2. The &nanal pedICIes and venous outflow at multivilanl 
allogratts. IVC. intenor vena cava: HA. hepaDC: a"ery; PV. ponm 
vewt; SA. SPlentC artery: SMA. supenor mesentenc artery; and 
SMV. supenormesentencvetn (SIarZI TE. etal: The manyfa«*ot 
mUlllYisceral tr~lflnK Sl.Ifg d~ Obstet 172:335. 1991. 
By permISSIOn of SUfgflty. GyneaJJogy & Obstetnes). 
these arteries can be anastomlZed directly to the recipient 
aorta above or below the level of the renal arteries or vIa 
an interpoSItion graft of donor aona. 
The venous ouutow from the grape duster is heplUOfu-
gal and is kept intact up [0 or beyond the liver. Composite 
transplants which inciude the liver are drained into a short 
length of retrohepauc inferior vena cava which may be 
used to replace the recipient vena cava or anastomosed 
.• pigyback" to the anterior wall of the retamcd recipieat 
vena cava (Fig 3). If any of the reSidua! splanchnic viscera 
arc retained. their venous drainage outflow can be into the 
vena cava. as jim Williams of Chicago was the tirst to 
SUgest,'l or into the porta! or superior mesenteric vein of 
the graft (Fig 3). 
For procurement. chilled solutions are infused into the 
arteria! supply. We have used the University of Wiscon-
sin (UW) solution althOUgh the experimentai studies of 
Schweizer et al ll of Kiel. Germany, and of Hamamoc.o 
worKing with Todo tn Pittsburgh'" sugacst that for the 
intestine this may be inferior to the EUJ'OoCollins soiution. 
Fluid volume to the nonheJ)alic viscera should be mmimIi. 
something which Alan MacDonald of Halifax empbuized 
for the pancreas more than two decades ago. if neccssuy, 
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o Retained organs 
o Donor organs 
Fig 3. Uver-small intes1lnaJ transcJIantaIIC In WhIctI a segment ot 
donor retrOhep8bC vena cava is used to replaCe the exCllMld 
reaplent. Note that the venous outtIow ot the retanld reQOI8nt 
Viscera IS directed into the reapent mtenor vena cava (IVC) by 
Donacaval shunt. Inset: "P1ggybIIcK" m8lhoc1 of tranIOIII1t venous 
. dratnage WIth 8nastomos1S ot the graft Infenor vena cava to the 
antenor wall ot the reIIIIn8d ~ Inferior vena cava. Note. ttle 
adclitional ootJan of anuDTIOIIIlg hi ~ portIS YeII'I (PV) to 
the graft ponaI V8If1 •• rnaneuwr deIIgnea to K~ the ~ 
allograft to hewtDIIOCbC ccnMIIUer81rom the ret8IWd YiIctfL 
The tecnnlQU8l are eSlel'lClally the same u for the lull mutIivia-
ceral procedure CStarzi TE. et at: The many feces 01 mutIiviIceraI 
tranaplantatJon. Surg Gynecal a.. , n:335. 1991. By permIII-
sion ot Surgery, d~ 41 0bsaIn:s,. 
the liver can be more completely perfused in isolation from 
the rest of the specimen through a separate catlleter 
in~ened through the inferior mesenteric vein and advanced 
into the hel)auc hilum. 1o 
Complete muttivisccra! transplantation has been per-
formed in a handful of patients with unquestioned function 
of the several orpns. Our 3V2-year-old child of 1987 was 
trealed with CyA and died after more than 6 months 
postoperatively from an Epstein-Barr virus associated 
lymphoma tn the graft.'I A paDent of Raimond Maqnmer 
died of recurrent carcinoma of the paacn:as after nearly 9 
months. Recently. I leamed of a sUMViI1l panent in 
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Carrel patch 
f~sKA;d""-pMA (0) 
~-- SMA(R) 
F1g 4. The rec:iCMnt operaUon after removal ot the host organa 
under venovenoua Oypasa (inset,. inser1ion ot the cluster graft. 
canl!)letiOn of ttIe vena caval anaMOmoset above ana betow the 
Ir.. and 8"&ltOIll0" ot the Carrel pau:n to the aorta at ttl. 
naual IOcaIion of the celiac axi8. CA • ceUc 1IXlS. SMA(O) -
suoenor mesenteric artery ot the donor. SMA(R) = superiOr 
m~ arteI'Y 01 the recIIlient. SMV(D) - suoenor mesemenc 
v8!ft of ttla aonor. and SMV(R) - supenor mesemenc vein of the 
reaoient (Starzi TE. et aI: AbdornmaI organ cluster tranaoIant8IiOn 
for the treatment of upper Ii:ldaminal maltgnanCl8S. Ann SUI9 
210:374.1989. Used with pemII8IOnl. 
Strasbouq who has passed the 4-month mark. Here. in 
London. in what is a landmarlt aclUevement. there is a weU 
patient who will soon reach the l-year marit. The indica-
tion. for this operation will be rare. but the information 
learned from it can be prodigious. 
CLUSTER TRANSPlANTATION 
Cluster transpiancation. whicb is derived from the multi-
vi5CCfBi operation. is with the same basic organ complex 
from which the stornacb above and the intestine below are 
removed. 13 These replacement grafts have beea used after 
upper abdominal excenteration for eXlCDSlve tumon. The 
operation is shown schemalically in Fig 4. including the 
use of a venovenous bypass to dccorftl'l'CSS the temporarily 
obstructed venous return from the recipient Inle$tincs and 
inferior vena cava. Bec:auae patients subjected to cluster 
operations develop serious nutritional problems. the stom-
ach was retained in one patient who died 14 days postop-
eratively from a sqmema& venous infarction of the ~ 
• j 
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Fig 5. GasamnleStii IaI senes. 6 
days after 0J)8rU0n. showing 
homograft duodenum and 18JU-
num In conllrUly WlttI the pa-
tient's own stomac:n and jeJurun 
(left). TechnIqUe used (rightt. To 
preserve the raapem celiac IXIS 
anc:lleft gastnc artery. it Will nec-
assary to Place .. donor CamII 
palCh below lhe left renal V8In 
and the r~ supenor mes-
enteric artery (StarzI TE. at at: 
AbdomJnal organ cluster trans-
plantatIOn for the lreaunent of 
upper abdOmInal mallgnanaes. 
Ann SUfi} 210:374. 1989. usee 
wltn permiSSIOn,. 
ient (not donor) Jejunum. The tragedy. as we heard in 
J eejeebhov' s opening remarks at this meenng. was that the 
attempt to salvage the flawed segment of jejunum was not 
jusnfied because this piece of intestine was not needed. 
The transplanted stomach was completely nonnai at au-
topsy. MaJ'RI'Clter' s patient and the London muttiviscerat 
recipient have demonstnlted the feasibility of gastnc trans-
plantation. 
Of paruc:ular interest for this conference were three 
patients whose grafted duodenums and shan segments of 
jejunum joined the mainstream gasuointestinai continuity 
as segmentai gnlits which were expected to function from 
the time of operation (Fig 5). In one of these patients. 
endoscopIc biopsies of the duodenal homogrUt showed 
rejectIon at 3 weeks. widespread replacement of the duo-
dena! mucosa with granutation at 2 months. but nonnai 
histopatbolotJic structure at 1 and 2 yean. This patient IS 
clinically weU after nearly 3 yean. having demonstnlted 
the enormous capacity for intestinal regeneranoR. 
Another of these three patients. whose original diagno-
sis was carciDoma of the cecum with he1'8lic: metastases. 
developed a.nqJUilary dysfunction of the graft common 
duct necessitating secondary duct anastomosis to a Roux-
limb of recipient jejunum at a very difficuit second opera-
tion. She died of recurrent c:an:inoma after 9 meruits. 
What rote dencrYation plays in the funenoR of the 
viscera! grafts and whether this was responsible for the 
am~uifary dysfunction. needs further examination. Fresh 
from an earlier life in n~ysiologyK 1 attcml)ted an 
anaiysis 30 yean ago of the intcmll)tcd ncurat pathways IR 
my ongmal article on muitivisc:crai trans~lantatilo (Fig 6). 
This negtCClCd area of researc:n relating spccUically to the 
intestlne was discussed earlier this week. paruculariy in 
the repon from NebrasD. 
Cluster OlJCnIions wen: performed 21 times in Pitts-
burgb I III to more than 3 years ago and. on a number of 
STAAZL. TOOO. TZAi<1S ET AL 
unreponed occasions. elsewhere. Our 3-month mortality 
was 24%. usually related to graft pancreatitis. Seven (33%) 
of these patients still arc alive. six an: tumor free after 21 
to 38 months (Table 1). 
UVEA-INTESTINAL GRAFTS 
The liver and intestine were transplanted together by 
Munci Kalayogtu of Wisconsin in December 1988. but not 
!! \..'-' S,," oi diV\llGft of nerve IUfiPiy 
e CawIcM', / ! i -- , t--__ .... -. .... 
~ , 
"la 
AI L SIIIaIt of del ....... , of ~ 0fg8rt graft (StIrZI TE. It 
at: HOii ....... ~D of II'IUIIII* ~ ~ Am J S4I9 
103:218.1982. Used Wilt pemaajOjll. 
c. 
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rllb6e 1. OrIgIMA ClUIW 
Ou..-wIV 22. 1988 10 s.c..ar 20. 1991 
FotIow-tJp 
Alive 
• No eIIIOInca 01 ~: I: 1M WIll ~ t. 
23-38 rncmns 
7 of 21 (33.3%)" 
reported until now. His patient rejected transplantation 
and. died after 52 days. We all know the ~nt 
acbievement of Grant et ajl6 who began wuh their first case 
in November 1988-and fanned the embers into 11amcs. 
The index patients of the Ontario team are now nearing 
the end of their third and second postoperanve years. I 
have become a pen pal of the second patient. and finally -
met her yesterday. Seeing the lovely and functional 
woman was more informauve and encouragmg than any to 
scientific articles. 
With thiS multiviscerai vanation. the small bowel and 
liver are retamed in contlnultv. removmg the other grapes 
from the stem vascular structures I Fig 3). Removal of the 
discarded organs can be done piecemeal at the donor 
operation or on the back table. The most inacc:essible 
vessel. the supenor mesenteric vetn. is approached by 
insertIng a finger along its avascular anterior suriacc. and 
transsecting the neck of the pancreas. This allows the 
numerous media! and latera! splanchnic tributanes to be 
ligated under direct Vision. The uncinate process and 
duodenum are thrown awav. 
We have treated two ad~lts and six children wtth this 
operation teases 2 through 9) WIth follow-up times noted 
for each case listed in Table 2. The recipient operations 
and aftercare were by Satoru Todo and Andreas Tzakis. 11 
Seven or the eight patients are alive after 6 weeks to 14 
months. some with spectacular rehabilitaUon. However. it 
WIll be emphasized in detail by Tzakis how difficult it has 
been to care for these patients. Only three of the patients 
are completely well. A stampede to do these cases is an 
invitation to disaster. 
ISOLATED INTESTINE 
There was one further case of isolatcd intestinal transplan-
tation with present survival of more than 1 Vz years (Table 
2. patient II. This operation invoivcs the same principles. 
-----------------._-
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but with removal of all the other grapes from the cluster. 
Dr Tzakis could relate his experience with the troubled 
coune of this pauent wllo is half success-half failure. 
INTESTINAL SEPSIS 
The restoration of gastrointestinal continuity is dependent 
on the nawrc of the aIlocraft. We have used extenorizing 
ostomies because prolongect enteric decompression usu-
ally is required postOperatively. Full continuity is restored 
later. after the intestine has settled in and is free of 
rejection or other complications. Before doing this. the 
patient must be free of infection. 
The intestine is the Acbilles heel in all the abdominal 
multiorpn variations. It has appeared to be more vulner-
able to rejection than the liver and other organs. When 
rejection occun. bacteria! leakage through the disrupted 
barrier follows. even with minimal mucosa1lesions. With 
the next stage of cryptttis. the intestine becomes a leaky 
sieve. The problem and solution are based on the same 
principles in more extreme form that were identified with 
the liver in the 19605. A description of liver sepsts wntten 
In 19691• could be transposed unchanged to 1991. 
The paradox was the use of strong immunosuppression 
with its known adverse effect on infection control to 
prevent rejection. but for the opposite objective: "It is 
almost ironical to state that one of the most important 
ways to prevent tbis peculiar form of liver infection is to 
provide very heavy immunosuppression. especially during 
the earty postoperative period. Adherence to the converse 
policy of minimum immunosuppression ... was a key 
factor in at least some. and probably all. of the consecutive 
tragedies of that era ... [A steroid increasel was the only 
real adjustment that could be made since there was little 
maneuverability in the use of azathiopnne and ALG." 
IMMUNOSUPPRESSION 
We owe much to the brave patients and their doctors in 
Europe (Deitz. Ricour. Goulet. Margreiter to mention only 
four): the Canadian groups in Toronto (led by Zane Cohen. 
whose name should not be omitted in such discussions) 
and in this special place of London: and in the United 
States (Richard Lillehei and others) who have brought us 
rllb6e 2. ~ 8nIIIII BOWIIi T, ••• 11 I II 
PIlIInI Aqa Sa TI. __ -.' O_afT. GtIIIt II-.. FuncIan 
1 31.1 M SlMII bowel _2.1990 P ... • 
2 2.3 F ~bowef July 24. 1990 Good 
3 26.7 F ~bowef Au9&* 3. 1990 Good 
4 4_3 M UvwI8lMll bowel ~O4K199l Good 
5 2.8 M ~bowef MMn24.1991 P ... ·T 
6 0.5 F ~bowef Au9&* i. 1991 Died.. GVHD 
7 1.0 F ~bowef Au9&* 10.1991 P .... ·T 
8 1.5 F Uvw,.,.,.. bowel Au9&* 12. 1991 P ... ·, 
9 21.0 M Uvw,.,.,.. bowel Au9&* 21. 1991 P ... ·, 
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this far. Perhaps. we can go further with the new immu-
nosuppressive drug. FK 506. which was used to treat all 
nine of our last patients. 17 
Our most prorrusing expenmental work with FK 506 by 
Murase et ai l9 has been in rats who survive routinely after 
transplantatIOn of either the intestine alone or of a com-
plete multiviscerai graft. Murase showed the weights of a 
series of near nonnaily growing rats. In the Brown-Nor-
way to Lewis strain combinauon. FK 506 can prevent 
rejection as weil as the development of OVHD. 
In these rats. a critical observation was made by Murase 
with monoclonai antibody phenotype detection techniques 
developed by Iwaici and Demeuis and their associates in 
Pittsburgh. Within 2 weeks. a massive replacement oc-
the I m oreticular cells of the intestine b 
~ Q..,l( lymphoid cells of the reCIpient. The original 
donor epithelium rerruuned. but It rested on a recipient 
Iymphoreucular bed in the lanuna propna. The changes 
were In the Peyer" s patches as well. and in the grail 
mesentenc lymph nodes. 19 
:\ local graft chimera was systematically created under 
FK 506. In reporung this. we neglected to cite a brilliant 
prevIous study published by Arnaud-Battandier of Ricour 
and Goulet'S group who showed the same finding in 
swine.;:o The French team had not cited their own inves-
tigations in subsequent anicles. and we failed to find this 
worK which was published in 1985, 
These observations changed our therapeutic strategy for 
GVHO control in the recent human cases. In our earlier 
multiviscerai recipients treated with Cy A. the graft lym-
phoid population was depleted by donor pretreatment with 
OKTI and by irradiation of the intestine after it had been 
implanted. These steps. which were supponed by rat 
studies of Shaifer and Monaco in Boston.;1 were omitted 
in all of the FK S06 cases. 10.17 
In these pauents. circulating donor lymphoid cells were 
found dunng the first postOperative month.ll an observa-
tion also recorded in the first pauent of Grant and Wall i • 
without clinical evidence of OVHD. GVHD was not seen 
in our series except in a patient whose immunosuppression 
was lightened because of a technicai complication. The 
circ:uiating donor ceils disappeared after a few days or 
weeks. Where these cells go was the subject of other 
papers at this meeting. panicuiarty one by Murase et ... 
which has been published elsewhere.;J The distribution is 
diffuse. even including the thymlJSo-<spec:iaily when 
G VHO develops. 
In the human intestine gnsft itself. it was shown as in the 
rat that ly~ucular repopulation of the intestinai 
lamina propna oc:c:urRd with replacement by cells of the 
!'CClpient but Wlth maintenance of donor epithelium.;z 
Both class 1 and class 11 cells paruci~K The time for 
this to be complete has been 45 to 90 days. Amongst the 
rectpient cells now in the graft are those whicb produce 
IgA and. on the endothelial surface. SecretOry IgA can be 
seen with monoclonal staining as Nakamura et all4 
showed. 
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Thus. intestinal graft chimerism is a central event in 
human as weU as rodent and pig intestinal recipients. 
Achievement of this Stale obviously is dependent upon 
powerful immunosuppression. It is of histone interest that 
K.A. Poner showed this special kind of chimerism in our 
liver transplants 22 years ago.:.s and that John Fung 
reponed the same thing in hean-Iung grafts in 1986.16 I 
now believe that it is a genera! phenomenon with all solid 
organs. differing only in the extent of the ceU tratIic. 
NONIMMUNOLOGIC RELATIONSHIPS 
Finally. I shouid note the importance of noninununologic 
factors in the success or failure of abdomina! organ grafts. 
N onnaily, the venous etHuent from all of the nonhelJllic 
splanchnic organs contributes to the penal blood suppiy, 
assuring first-pass delivery to the liver of intestinal nutri-
ents. and of the so-called penal hepalotrophic substances 
which are important for normal hepatocyte struc:wre. 
function. and the capacity for regeneration.;1 The hepa-
totrophic factors. of which endogenous insulin is the single 
most important. are muitiple and apparently cumuiative. 
Thus. when partiai multivisc:erai grafts are used. such as 
the liver-intestine. it is preferable to direct the gastroduo-
denal-pancreatic effluent from the retained recipient or-
gans as well as from the intestinal graft into the porta1 
circulation of the new liver (Fig 3). Otherwise. subtle 
injury of the liver can be expected as occurred in one of 
our liver-intestine recipients whose native pancreaticoduo-
de no-gastric effluent was bypassed around her liver graft. 
The hepatic graft developed histopathologic findinp typi-
cal of. although less than. those after Eck fistula. These 
eventually stabilized with a satisfactory result. 
Another consideration of ponal versus systemic drain-
age of the intestine is worthy of mention. In a classi<: study 
published in 1945. the distinguished phYSician_ Paul Bee-
son. showed that the liver is the most etfective of all human 
organs in filtering out bacteria in the blood stream. a Thus. 
the liver stands as a barrier between the transpjaated 
intestine and systemic bacterial translocation. A decision 
not to use it. which is implicit with drainage into the vena 
cava. should not be taKen lightly. 
Nowhere can the linkqe between the past and pracat 
be seen more clearly than in Beeson's writinp. The 
bacterial gradients across central vital organs were deter-
milled in some of the first patients in the world submiucd 
to the then new cardiac catheterization techniques. These 
also were amonpt the last patients with bac:teria1 en-
docarditis. who were doomed. because perucillin and other 
antibiotics were not yet available. The pamful dic:bocomy 
of pure investigation versus treatment was fresil in 
Beeson's mind 40 years later when he concluded that be 
probably would not permit such studies if he sat today on 
a modern Institutional Review Board.l9 Yet. the results 
were irn.mona.l and can help us today. providing we know 
of their existence. 
Now in his 80s. Beeson lives in Redmond. Wasbiqron. 
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I met him and other ancient warriors at a reunion in 
Pittsburgh In 1 une 1991 of those left from this eartier 
generation. With him was George Thorn. one of the 
founders of the Peter Bent Brigham kidney transplant 
program. There IS much to learn from wIse men like these. 
Aside from its infectious significance. the liver has long 
been thought to be a screen for tOXIC substances and 
antigens absorbed from the intestine. if. as suspected. the 
liver can diminish the immunologic response by modifying 
allograft antigens or the action of immunoreactive cells in 
the recipient. directing the venous output of intestinal 
grafts into the portal vein land through the liver' could 
provide a therapeutic advantage. Many articles 'summa· 
rized to 1977 in ref. 30) have been published claiming such 
an effect. However. in our own eartier studies. carried out 
with Giuseppe MazzoOi. we were unable to detect a 
difference In rejection of pig or dog allografts which were 
drained into the portal versus the systemIc circulation.)O 
Similar! Y. the results reponed at this meellm~: by Li et al J I 
of London and Murase et alJl of Pittsburgn did not show a 
difference In rejection with portal versus vena caval drain· 
age. 
CONCLUSION 
I carne here today mainly to pay homage to the intrepid 
pioneers. many here today and others now dead. who had 
the conviction to persist with what must have seemed like 
vain and hopeless efforts stretching baCK a third of a 
century. Now. there IS evidence that the intestine wJil be 
joining the family of organ transplants. 
As Tzakis WIll emphasize in a few minutes. we must not 
spoti the VIctOry by ove'1'laying our hand and beginmng a 
mad race to the gold fields. We must remember that we 
have consIstently succeeded so far only in transplanting 
the cadaver Intesttne with the advantage of a companIon 
liver. The only long survivors so far with intestinal trans-
plantation alone are the child reported at this meeting by 
Goulet et aI of Paris t2Yz years' and the adult in Pittsburgh 
(I'll years I. This is the operation which will have the 
greatest use if it can be perfected. 
A real tearn is needed for these trials. Remember that 
not every place can have a Cal Stiller. a Bill Wall. and a 
David Grant together. People like this cannot be bought 
like high·priced basebaH playen and quicldy assembled 
into a umt. They can only be thallked and admired. So. my 
Canadian friends. thanlc. you. 
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